Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2000
11/30/2000CA2716369A1 Phenoxypropylamine compounds
11/30/2000CA2684016A1 Methods and compounds for inhibiting amyloid deposits
11/30/2000CA2382774A1 Meth1 and meth2 polynucleotides and polypeptides
11/30/2000CA2381441A1 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
11/30/2000CA2374937A1 Oral administration of lactobacillus for the maintenance of health in women
11/30/2000CA2374926A1 Thiazoloderivatives and pharmaceutical compositions containing them
11/30/2000CA2374915A1 Substituted imidazothiazoles as antidepressant agents
11/30/2000CA2374674A1 Tumor necrosis factor receptor 5
11/30/2000CA2374532A1 Recombinant bacterial phytases and uses thereof
11/30/2000CA2374273A1 Liver function controlling agents
11/30/2000CA2373693A1 Seven transmembrane receptor genes
11/30/2000CA2373577A1 .alpha.-amino-.beta.-sulfonyl hydroxamic acid compounds
11/30/2000CA2373221A1 Human antibodies to staphylococcus aureus
11/30/2000CA2372743A1 New pharmaceutically active compounds
11/30/2000CA2372567A1 Indole-type derivatives as inhibitors of p38 kinase
11/29/2000EP1055668A1 New 4-arylpiperidine derivatives for the treatment of pruritus
11/29/2000EP1055665A1 3-(3-Hydroxyphenyl)-3-amino-propionamide derivatives
11/29/2000EP1054995A1 GABAB-R2a, A 7TM RECEPTOR
11/29/2000EP1054905A1 Derivatised antibodies with exposed carbohydrate chains capable of binding to immobilised igg
11/29/2000EP1054904A1 Mucilage, a g-protein-coupled receptor
11/29/2000EP1054900A1 Therapeutic uses of keratinocyte growth factor-2
11/29/2000EP1054887A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
11/29/2000EP1054884A1 Benzofuran-4-carboxamides and their therapeutic use
11/29/2000EP1054881A1 Novel sulfonamide substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
11/29/2000EP1054877A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
11/29/2000EP1054869A1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors
11/29/2000EP1054858A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
11/29/2000EP1054857A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/29/2000EP1054678A2 Combination of steroid and polyunsaturated fatty acids for treatment of inflammatory conditions
11/29/2000EP1054642A1 Light-activated tooth whitening composition and method of using same
11/29/2000EP0896539B1 Use of optically pure (+) norcisapride for treating emesis and central nervous system disorders
11/29/2000EP0784753B1 Axial flow valve system in combination with a linera compressor
11/29/2000EP0655055B1 Tachykinin antagonists
11/29/2000CN1275129A Oligosaccharide derivatives and process for producing the same
11/29/2000CN1274592A Enterogastric disease treating medicine and its preparation
11/29/2000CN1274585A Kuiyangling as one kind of Chinese medicine for gastroenteritic diseases
11/29/2000CN1058965C New thiophene compounds, process for their preparation and pharmaceutical compositions containing them
11/29/2000CN1058964C Branched-amino-sbustituted thiazoles, process for their preparation and the pharmaceutical compositions which contain them
11/29/2000CN1058903C Chinese-medicine without laxative for relaxing bowels
11/29/2000CN1058890C Chinese medicine powder for curing gastroenteritis
11/29/2000CN1058887C Chinese medicine composition for treatment of intestines and stomach trouble
11/29/2000CN1058875C Health-care adhesive plaster for removing food stagnancy for children and prepn. method thereof
11/28/2000US6153739 Polynucleotides encoding human uridine diphosphate galactose-4-epimerase
11/28/2000US6153655 Terminally-branched polymeric linkers and polymeric conjugates containing the same
11/28/2000US6153650 Treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammation, and gastrointestinal damage.
11/28/2000US6153628 1,3,4-thiadiazoles and 1,3,4-Oxadiazoles as αv β3 antagonists
11/28/2000US6153626 For treating pain, gastrointestinal disorders, spinal cord injury
11/28/2000US6153609 Arylsulfonylamino hydroxamic acid derivatives
11/28/2000US6153591 Protecting nervous system following focal ischemia and global ischemia; alzheimer's disease, huntington's disease, prion diseases, parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, alopacia, rheumatoid arthritis
11/28/2000US6153396 Drug screening by adding compound to mixture of chaperone and pilus subunit and determining the change in binding; bactericides for urinary tract infections
11/28/2000US6153390 Isolated antigenic polypeptide from helicobacter pylori; for immunoassay diagnosis
11/28/2000US6153378 Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus
11/28/2000US6153220 Taste-masked formulations
11/28/2000US6153210 Use of locally delivered metal ions for treatment of periodontal disease
11/28/2000US6153189 Human TRK receptors and neurotrophic factor inhibitors
11/28/2000CA2309505A1 New 4-arylpiperidine derivatives for the treatment of pruritus
11/28/2000CA2309434A1 New 4-arylpiperidine derivatives for the treatment of pruritus
11/28/2000CA2192820C Pyrazolo and pyrrolopyridines
11/28/2000CA2068943C 1,3-oxathiolanes useful in the treatment of hepatitis
11/23/2000WO2000070091A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF HUMAN PROTEIN KINASE C-δ EXPRESSION
11/23/2000WO2000070049A2 Extracellular signaling molecules
11/23/2000WO2000070047A2 Full-length molecules expressed in human tissues
11/23/2000WO2000070046A2 Secreted polypeptides and corresponding polynucleotides
11/23/2000WO2000070042A1 143 human secreted proteins
11/23/2000WO2000070025A1 Methods of using rnase p reaction mechanisms of action
11/23/2000WO2000069913A1 EXPRESSION AND EXPORT OF INTERFERON-ALPHA PROTEINS AS Fc FUSION PROTEINS
11/23/2000WO2000069905A1 LAWSONIA DERIVED GENE AND RELATED OmpH POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
11/23/2000WO2000069904A1 LAWSONIA DERIVED GENE AND RELATED FlgE POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
11/23/2000WO2000069903A1 LAWSONIA DERIVED GENE AND RELATED SodC POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
11/23/2000WO2000069900A2 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
11/23/2000WO2000069890A1 Prevention of dental caries
11/23/2000WO2000069861A1 THIAZOLOPYRIMIDINES USEFUL AS TNFα INHIBITORS
11/23/2000WO2000069859A1 Imidazo- and pyrrolo[1,2-a]pyrimid-4-ones as gonadotropin-releasing hormone receptor antagonists
11/23/2000WO2000069848A1 Compounds having cytokine inhibitory activity
11/23/2000WO2000069847A1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
11/23/2000WO2000069838A1 Ion channel modulating agents
11/23/2000WO2000069831A1 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
11/23/2000WO2000069824A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/23/2000WO2000069823A1 Ion channel modulating agents
11/23/2000WO2000069821A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/23/2000WO2000069820A1 Cyclic amine derivatives and their uses
11/23/2000WO2000069818A1 MORPHOLINO-N-ETHYL ESTER DERIVATIVE OF AN INDOLE sPLA2 INHIBITOR
11/23/2000WO2000069472A2 Enzyme-activated anti-tumor prodrug compounds
11/23/2000WO2000069470A2 Improved cellular uptake of bioactive agents
11/23/2000WO2000069455A2 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus
11/23/2000WO2000069451A1 A method of identifying therapeutic compounds for a treatment of hepatic disorders
11/23/2000WO2000069449A2 Conditioned cell culture medium compositions and methods of use
11/23/2000WO2000069428A2 Anionic polymers as toxin binders and antibacterial agents
11/23/2000WO2000069277A1 A composition containing carvacrol and thymol for use as a bactericide
11/23/2000WO2000069257A2 Genetic modification of male germ cells for generation of transgenic species and genetic therapies
11/23/2000WO2000069255A1 Anti-inflammatory therapy for inflammatory mediated infection
11/23/2000WO2000043371A3 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
11/23/2000WO2000043354A3 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4
11/23/2000WO2000030681A9 Antagonists of the alpha e beta 7 integrin as therapeutic agents for inflammatory diseases
11/23/2000WO2000026348A3 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity
11/23/2000DE19922462A1 New phenylureidobenzyl-substituted spiro-imidazolidinedione derivatives, are inhibitors of leukocyte adhesion or migration or VLA-4 receptors, useful e.g. for treating inflammatory or allergic disease
11/23/2000CA2623458A1 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
11/23/2000CA2505617A1 Modified secretin and method of synthesizing thereof
11/23/2000CA2499211A1 Modified peptides yy and conjugates thereof
11/23/2000CA2374559A1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
1 ... 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 ... 1258